|
|
|
|
| LEADER |
00000nam a2200000 a 4500 |
| 001 |
ocn613429205 |
| 003 |
UV# |
| 005 |
20151110123418.0 |
| 008 |
151110s2011 nyua b 001 0 eng d |
| 010 |
|
|
|a 2010027290
|
| 020 |
|
|
|a 9780071635004
|
| 020 |
|
|
|a 0071635009
|
| 040 |
|
|
|a DNLM/DLC
|b spa
|c DLC
|d YDX
|d NLM
|d BTCTA
|d UKM
|d YDXCP
|d CDX
|d EUM
|d IG#
|d MMU
|d STJ
|d OCLCF
|d P4I
|d UV#
|
| 050 |
0 |
4 |
|a RM302.5
|b U52 2011
|
| 082 |
0 |
0 |
|a 615/.7042
|2 22
|
| 245 |
0 |
0 |
|a Understanding pharmacoepidemiology
|c / editors, Yi Yang, Donna West-Strum.
|
| 260 |
|
|
|a New York :
|b McGraw-Hill Medical,
|c ©2011.
|
| 300 |
|
|
|a x, 197 páginas :
|b ilustraciones ;
|c 24 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|
| 504 |
|
|
|a Incluye bibliografías e índice
|
| 505 |
0 |
|
|a Introduction to pharmacoepidemiology -- Principles of epidemiology applied to the study of medication use -- Study designs for pharmacoepidemiology -- Using secondary data in pharmacoepidemiology -- Biostatistics and pharmacoepidemiology -- Other methodological issues -- Evaluation of pharmacoepidemiology literature -- Medication utilization patterns -- Medication safety and pharmacoviligance -- FDA perspective on postmarket drug safety.
|
| 650 |
|
4 |
|a Farmacoepidemiología
|9 420671
|
| 700 |
1 |
|
|a Yang, Yi,
|d 1968 Marzo 31-
|9 420680
|
| 700 |
1 |
|
|a West-Strum, Donna
|9 420681
|
| 942 |
|
|
|c LIBRO
|6 _
|
| 999 |
|
|
|c 295261
|d 295261
|
